Consequently, GLP-1 analogues such as liraglutide, exenatide, semaglutide, and lixisenatide, engineered to resist DPP-4 cleavage, are now utilized for managing T2DM [198,199]. Here, GCG is linked to type 2 diabetes mellitus.